Our #clinical stage pipeline is based on dopamine-somatostatin chimeric molecules for the treatment of rare #endocrine disorders. To learn more, click here: bit.ly/34Stlnb
1
#DYK that the most common symptoms of non-functioning #PituitaryAdenomas, such as vision loss and severe headaches, are due to the tumor compressing nearby structures in the brain? To learn more, click here: bit.ly/2TnYlXx
At Tiburio, we are dedicated to developing transformative treatments for #RareEndocrine diseases. To learn more, click here: bit.ly/2KmVzgu
Data demonstrating that our lead candidate is capable of halting the growth of non-functioning #PituitaryAdenomas in mice was featured by Drug Discovery News (@DDNewsOnline). Read the full article here: bit.ly/2Bd0waG
Are you interested in keeping up with our latest news and events? Register to receive updates here: bit.ly/2CnKk6p
We know that the development of meaningful and sustainable products requires a deep understanding of #patients’ and #physicians’ perspectives on treatment needs. To learn more about our commitment to helping patients with #RareEndocrine disorders, visit: bit.ly/38H1TdN
1
In this podcast episode of The Long Run with Luke Timmerman, our CEO Abe Ceesay (@ceesabe) speaks with Luke Timmerman (@ldtimmerman) about his path to leadership. Listen here: bit.ly/33n8f1i
1
#DYK that non-functioning #PituitaryTumors (NFPAs) are the most common non-cancerous tumors that grow in the pituitary gland? Learn more about why these tumors are called 'non-functioning' here: bit.ly/2W0EOxy
Non-functioning #PituitaryAdenomas (NFPAs) can have a significant and lasting impact on #patients. To learn more about the effect of NFPAs, read impactful stories from patients here: bit.ly/322TlNc
Our leadership team of #endocrine and #RareDisease experts is committed to building lasting relationships with patients, their families and the clinical community. Read more about who we are: bit.ly/2BTVss1
#DYK that the #pituitary is an #endocrine, or hormone-producing, gland that is located at the base of the brain? This gland plays a critical role in the human body. To learn more, visit: bit.ly/38H1TdN
Currently, there are no approved medical therapies to treat non-functioning #PituitaryAdenomas (NFPAs). NFPAs are pituitary tumors that disrupt critical structures in the surrounding area of the brain as they grow. Learn more: bit.ly/38H1TdN
1
Our CEO, Abe Ceesay (@ceesabe), was featured in a Pharma’s Almanac (@pharmasalmanac) article, where he discussed how Tiburio is developing transformative treatments for rare #EndocrineDisorders with a focus on non-functioning #PituitaryAdenoma. Read here: bit.ly/2ZirxCV
Our VP of research, Dr. Heather Halem, & Dr. Michael Culler, scientific founder & chair of our scientific advisory board, wrote an article about chimeric compounds & the treatment of #PituitaryTumors for Drug Development & Delivery. Read the article here: bit.ly/2O6n4wC
Our CMO, Nerissa Kreher (@KreherNerissa), was featured in The Chief Medical Officer Summit's (@ConferenceForum) May newsletter, where she discussed the role of a CMO, overcoming challenges & her work with Executive Women in Bio. Read the newsletter here: bit.ly/2DjauYy
Nonclinical data demonstrates our lead clinical asset, TBR-760, inhibits the growth of aggressive non-functioning #PituitaryAdenomas in mice. Read the full manuscript in @EndoSocJournals here: bit.ly/2YJ25WU
We're advancing a chimeric compound for the potential treatment of a type of #PituitaryTumor known as a non-functioning #PituitaryAdenoma & want to help raise awareness of it & other #BrainTumors! #BRAINFEST is an event dedicated to doing just that: bit.ly/2TpGXBV
3
.@TheEndoSociety Online 2020’s virtual meeting published pre-clinical data in the Journal of the Endocrine Society's demonstrating that our lead clinical asset TBR-760 inhibits the growth of non-functioning #PituitaryAdenoma (NFPA) in mice. Learn more: bit.ly/3fGQ6ze
The #BrainTumor community is especially important to us & we're dedicated to developing treatments for non-functioning #PituitaryAdenomas, a type of #PituitaryTumor. #ICYMI, the @NBTStweets Boston Brain Tumor Ride is virtual! Find out more here: bit.ly/3fuzbjr
1
We're committed to developing transformative treatments for patients w/rare endocrine diseases & excited to learn that Rare Diseases Europe (@eurordis) is hosting its European Conference on Rare Disease & Orphan Products online! #ECRD2020 Register here: bit.ly/2WbLsSq